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Background Intrauterine growth restriction is a cause of neonatal
morbidity and mortality. A variety of definitions of low
birthweight are used in clinical practice, with a lack of consensus
regarding which definitions best predict adverse outcomes.
Objectives To evaluate the relationship between birthweight
standards and neonatal outcome in term-born infants (at ≥ 37 weeks
of gestation).
Search strategy MEDLINE (1966–January 2011), EMBASE (1980–
January 2011), and the Cochrane Library (2011:1) and MEDION
were included in our search.
Selection criteria Studies comprising live term-born infants
(gestation ≥ 37 completed weeks), with weight or other
anthropometric measurements recorded at birth along with
neonatal outcomes.
Data collection and analysis Data were extracted to populate
2 9 2 tables relating birthweight standard with outcome, and
meta-analysis was performed where possible.
Main results Twenty-nine studies including 21 034 114 neonates
were selected. Absolute birthweight was strongly associated with
mortality, with birthweight < 1.5 kg giving the largest association
(OR 48.6, 95% CI 28.62–82.53). When using centile charts,
regardless of threshold, the summary odds ratios were significant
but closer to 1 than when using absolute birthweight. For all tests,
summary predictive ability comprised high specificity and positive
likelihood ratio for neonatal death, but low sensitivity and a
negative likelihood ratio close to 1.
Author’s conclusions Absolute birthweight is a prognostic factor
for neonatal mortality. The indirect evidence suggests that centile
charts or other definitions of low birthweight are not as strongly
associated with mortality as the absolute birthweight. Further
research is required to improve predictive accuracy.
Keywords Fetal growth restriction, low birthweight, neonatal
morbidity, neonatal mortality, systematic review.
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Introduction
Intrauterine growth restriction remains a significant prob-
lem in current obstetric and neonatal practice, and is a sig-
nificant cause of perinatal mortality and morbidity.1,2
Statistically ‘normal’ birthweight is defined as being within
a range around the central tendency (e.g. centile ranges).
This simple approach has many deficiencies. Clinically,
infants who are of low birthweight may belong to one of
four groups. There are those that suffer intrauterine growth
restriction, whereby the fetus does not achieve their growth
potential because of environmental factors, such as placen-
tal insufficiency or maternal health status.3 Others may
have a structural or chromosomal abnormality that affects
their growth.3 Another group of infants who have low
birthweight are those that are constitutionally small. These
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Systematic review
babies reach their growth potential; they are not subject to
a pathological process.4 Low birthweight also refers to
babies who are normally grown but are born prematurely.
Prematurity is independently associated with increased
mortality and long-term morbidity.5,6
A number of methods have been used to attempt to
identify infants who are most at risk of adverse outcomes,
including neonatal morbidity and mortality. These include:
population-based centile charts, with the most commonly
used threshold being the tenth centile7; customised charts,
where the mother’s body mass index (BMI) and ethnicity
are used to calculate individualised growth centiles8; and
ponderal index, which takes into account neonatal weight
and length.9 The published associations between each stan-
dard for defining growth restriction and adverse outcome
vary, and there is no current consensus regarding the best
method.10 Within current UK practice a variety of different
population and customised centile charts are used antena-
tally, with a different growth chart used for the postnatal
period, and with the absolute birthweight (<2.5 kg) often
being used to determine the need for increased care or
observation in the neonatal period.
The aim of this systematic review was to re-examine the
association between measures of low birthweight, including
absolute birthweight and other anthropometric measure-
ments, such as ponderal index, with adverse neonatal out-
comes. We attempted to avoid the confounding influence
of prematurity and to determine which definition of
growth restriction has the strongest prognostic association
with, and is the best predictor for, subsequent morbidity
and mortality.
In this article, the term ‘prognostic’ refers to the strength
of association between a birthweight test and the odds of
an adverse outcome, as measured by an odds ratio. The
term ‘predictive’ refers to the ability of a test to discrimi-
nate between babies who will and babies who will not
experience an adverse outcome, as measured by sensitivity,
specificity, and positive and negative likelihood ratios.
A test may have strong prognostic ability, but not necessar-
ily good predictive ability, and so it is important to
consider both.11
Methods
A protocol-driven systematic review was performed using
widely recommended methods for reviews (Appendix S1),12
and is reported according to the MOOSE (meta-analysis of
observational studies in epidemiology) guidance.13 This
study was performed as part of a larger systematic review
to determine the association of birthweight standards with
outcomes throughout life, and therefore the search strate-
gies and study selection process refer to the studies
included for the overall project. The articles relating to
outcomes in the neonatal period are reported in this arti-
cle, whereas those relating to childhood and adult out-
comes are reported separately.
Sources
We searched MEDLINE (1966–January 2011), EMBASE
(1980–January 2011), the Cochrane Library (2011:1), and
MEDION for relevant published articles. In order to iden-
tify ‘grey’ literature, OpenGrey and Web of Science were
also searched for relevant citations. In MEDLINE the
search consisted of a combination of medical subject head-
ings (MeSHs; e.g. infant, small for gestational age, fetal
growth retardation), keywords (e.g. intrauterine growth
retardation, low birthweight), and word variants using the
Boolean operator ‘OR’ for capturing citations of the rele-
vant text. These were combined using ‘AND’ with a combi-
nation of MeSHs (e.g. human development, infant
mortality, diabetes mellitus), keywords (e.g. developmental
delay, handicap, cardiovascular disease), and word variants
to capture relevant outcomes. The search was restricted to
human studies, but no language restrictions were applied.
The MEDLINE search strategy (Appendix S2) was adapted
for use in other electronic databases. Hand searching of
recent major journals was also performed. The search was
performed by two investigators: R.K.M. and G.M. A com-
prehensive database collating all citations was constructed
using REFERENCE MANAGER 12.0.
Study selection and data extraction
Initially, the database was scrutinised by two reviewers
(R.K.M. or G.M., partly in duplicate), and full articles of
all citations that were likely to meet the predefined selec-
tion criteria were obtained. Articles in languages other than
English were translated. Final inclusion or exclusion deci-
sions were made after examination by two reviewers (G.M.
and R.K.M.) in accordance with the most recent guid-
ance,12 and with strict adherence to the following criteria.
 Population: Live-born infants who have had weight or
other anthropometric measurements recorded at birth and
were born at term (gestation ≥ 37 completed weeks).
 Index test: Any measure of weight or growth at birth,
including: absolute birthweight (thresholds <2.5 kg,
<2.0 kg, <1.5 kg); population or customised centile charts
(thresholds <10th centile, <5th centile, <3rd centile); pond-
eral index or other growth ratios.
 Outcome: Any measure of compromise of neonatal,
childhood, or adult wellbeing, such as: mortality; neonatal
morbidity, including hypoxic ischemic encephalopathy;
childhood or adult motor disability; childhood or adult
disease, including diabetes mellitus, cardiovascular disease,
and hypertension.
 Study design: Observational studies that allowed the gen-
eration of a 2 9 2 table (true positives, false positives, false
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negatives, and true negatives) to compute an estimate of
the association between test result and outcomes. Studies
with five or fewer individuals were excluded on account of
unreliability.
All articles were carefully examined to identify duplica-
tions in population. Where this was identified, the most
recent and complete versions of the work were selected.
There was no language restriction in study selection. The
reference lists of selected studies and review articles were
scrutinised and additional relevant articles were obtained.
Information was extracted from the selected articles in
duplicate (G.L.M. and R.K.M.) using a data collection
sheet. Data were extracted on study characteristics (includ-
ing the threshold values used), quality, and results, and
were entered onto an EXCEL spreadsheet. Data were used to
construct 2 9 2 tables of the association between the mea-
sure of growth at birth using the threshold reported in the
article and the postnatal outcome for each individual. If
results for multiple thresholds were reported, we sought to
construct a separate 2 9 2 table for each threshold. In
studies where data were felt to be relevant but 2 9 2 tables
could not be constructed, or the outcome or population
reported in the article did not meet the specific inclusion
criteria, the authors were contacted. The study was not
included unless the specific data could be provided. Diffi-
culties in data extraction were resolved by seeking input
from a third reviewer (K.S.K.). From the overall data set,
the subset of studies reporting neonatal adverse outcomes
was selected for inclusion in this report.
Study quality assessment
All articles meeting the selection criteria were assessed for
methodological quality, defined as confidence that the
study design, conduct, and analysis minimised any bias in
the estimation of an association. We assessed quality using
the complete STARD and QUADAS checklists. These are
validated for the reporting and methodological quality of
diagnostic test accuracy studies, and we selected the quality
elements that were felt to be most relevant for this review
on prognostic tests and associations.14,15 We did not assign
a quality score, as this been shown to give flawed results.16
We considered cohort study design to be superior to case–
control design. A study was rated high quality if it had at
least four of the following items: an adequate description
of the population; an adequate description of the test (defi-
nition of low birthweight) and the outcome measure; con-
secutive recruitment; prospective recruitment; >90%
completions of follow-up; appropriate outcome measure-
ment; blinding of the investigators performing the outcome
measure, and a statement regarding the use of intervention
between the index test and outcome. A study was deemed
to be of medium quality when three criteria were met and
low quality if two or less were adhered to.
Data synthesis for prognostic association
The 2 9 2 tables were used to compute odds ratios (ORs)
and 95% confidence intervals (95% CIs) for each index
test–outcome pair, and the results were pooled for each
index test (considering each definition and threshold of
growth as a separate test) using meta-analysis. The OR was
selected as the summary statistic, as it represents the effect
of the exposure on the odds in an unbiased fashion and
enables the results of both case–control and cohort studies
to be included.17 It is frequently used to demonstrate an
epidemiologic association,17 and here it provides a measure
of a test’s prognostic ability.
With clinical and statistical heterogeneity expected
between studies, a random-effects model was used
throughout to account for this, which synthesises the log-
arithmic odds ratio estimates for each test and weights
each study by the inverse of the variance within the study
plus between-study variance. This method provides a
summary estimate of the average prognostic effect of a
test. As the prognostic ability of a test may vary from this
average from setting to setting, after each random-effects
meta-analysis, if I2 > 0% we also estimated a prediction
interval (EPI). This reveals the potential prognostic associ-
ation if the test is applied in a single setting similar to
one of the studies from our analysis.18 EPI was calculated
where three or more studies were included in the
meta-analysis.
We plotted summary OR data in forest plots and
assessed the between-study heterogeneity in the prognostic
association for each test by estimating I2 (the level of vari-
ability in prognostic effects arising from between-study
heterogeneity)19 and s2 (the among-study variance of the
true prognostic effect).20 Where the number of studies
reporting a given birthweight standard and outcome
allowed, we performed subgroup analysis to examine the
effect of potential confounding factors. Singleton or multi-
ple birth status, ethnicity, exclusion of congenital anoma-
lies, birth of the study population during or after 1990
(because of recent advances in antenatal and neonatal
care), and study quality were considered to be important
factors that may influence the strength of the association
between low birthweight and adverse outcome.
In each study, when a table contained cells with a value
of 0, 0.5 was added to all cells to allow the calculation of
log ORs and their variances for meta-analysis.21
Meta-analyses were performed where two or more studies
reported the same index test and outcome measure. The
primary outcomes were considered to be neonatal mortality
and a composite measure of neonatal neurological morbid-
ity and non-neurological morbidity. A composite outcome
measure for morbidity was employed to maximise the
number of events that could be included in the analysis
and avoid the need to select a single morbidity as a pri-
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mary outcome measure; however, a hazard of composite
outcome measures is the assumption that the significance
of the result applies to all components.22 To address this
issue, we analysed the component outcomes as subgroups.
When the composite outcome measure was used, care was
taken to ensure that each individual was only counted once
in each analysis, particularly where studies reported multi-
ple outcomes for a single population. Where multiple out-
comes were reported, attempts were made to select the
outcome that was most consistent with the other studies:
for example, in the neonatal non-neurological morbidity
analysis, hypoglycaemia was the most commonly reported
outcome and therefore this was selected primarily, followed
by other conditions. To explore for the presence of funnel
plot asymmetry (small study effects), and thus potential
publication bias, the Peters test was performed in each
meta-analysis containing at least ten studies.23
For the purposes of our meta-analyses, we used data
where birthweight had been dichotomised around a thresh-
old specified in the primary studies. In order to compare
the effect of birthweight when it was analysed as a continu-
ous variable, we examined all of the included studies where
logistic regression analysis had been performed with birth-
weight included as a continuous variable, and qualitatively
summarised the findings.
Data synthesis for predictive ability
Where there was a strong and statistically significant prog-
nostic association between a test and an outcome measure
(defined by an OR > 5, with a 95% CI > 1), we went on
to calculate sensitivity, specificity, and likelihood ratios,
again using data from the 2 9 2 tables and synthesising
predictive measures using a bivariate random-effects
meta-analysis model. This allowed us to examine the pre-
dictive ability of the test24: that is, whether the test can
accurately discriminate between those who do and those
who do not have a poor outcome (as measured by sensitiv-
ity and specificity), and how much a positive or negative
test result modifies the odds of a poor outcome (as mea-
sured by the positive and negative likelihood ratios).
All analyses were performed in STATA 10.0 (StataCorp,
College Station, TX, USA) using the metan, metandi, and
metabias commands.25–27 Plots were generated using STATS-
DIRECT.
Results
As shown in Figure 1, after an initial search of 36 956 cita-
tions, we included 92 primary articles in the overall system-
atic review, of which 29 contained data relating birthweight
standards to neonatal outcomes.7,9,28–54 Five of these were
included after contact with authors who provided data or
information.28,31–34 In total, data were available for
21 034 114 neonates. Details of the studies included are
given in Table S1; a list of excluded studies is available
from the authors upon request. A total of 145 further arti-
cles were felt to contain potentially relevant data, but the
authors could not be contacted, could not supply data to
create 2 9 2 tables, or upon clarification regarding the
population the study was excluded. If a study included
infants of <37 weeks of gestation, it was only included if
separate data regarding term infants was given or the
authors provided this. A number of studies contained
duplicate populations: where there was duplication of the
test and outcome measure the least complete study was
excluded from the review. If the population was the same
but the measure of growth restriction or adverse outcome
differed, then both studies were included, but care was
taken not to include multiple studies reporting from the
same population within a single meta-analysis, or within
the overall count of the number of individuals included in
the review.7,42
The majority of studies used population growth chart
below the tenth percentile (n = 17) or birthweight under
2.5 kg (n = 9) as the index test that defined fetal growth
restriction. A wide variety of neonatal outcome measures,
including mortality and morbidity (e.g. seizures, hypother-
mia, hypoglycaemia, respiratory distress), were reported.
For comparison, we grouped outcomes according to mor-
tality, neurological morbidity, and non-neurological mor-
bidity.
Prognostic association with neonatal mortality
A forest plot of the summary meta-analysis odds ratios and
95% confidence intervals for each measure of fetal growth
restriction in relation to neonatal mortality is given in
Figure 2. A birthweight below 1.5 kg showed the strongest
association with neonatal mortality (OR 48.6, 95% CI
28.62–82.53), with no between-study heterogeneity in this
effect. Raising the birthweight threshold to 2.0, 2.5, or
2.9 kg gradually reduced the association and increased the
heterogeneity, but the summary effect estimate remained
highly significant at each threshold. Population centile
charts were also strongly associated with neonatal mortal-
ity, but generally showed a weaker association at all thresh-
olds than absolute birthweight, because the summary ORs
were closer to 1 (Figure 2).
Prognostic association with neonatal morbidity
The association between measures of fetal growth restric-
tion and neonatal morbidity are given in Figure 3. The
analysis was subdivided into reported neurological morbid-
ity (including seizures, hypoxic ischaemic encephalopathy,
intraventricular haemorrhage) and non-neurological mor-
bidity (including hypoglycaemia, respiratory distress syn-
drome, cardiac failure), according to the definitions given
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in the primary studies. A birthweight below 2.0 kg was
most strongly associated with neurological morbidity
(OR 17.34, 95% CI 5.63–53.70); however, this was based
on a single study of 770 neonates. There was a significant
association between weight below the third, fifth, and tenth
centiles and neurological morbidity. A birthweight below
the tenth centile according to a customised growth chart
and a ponderal index of ≤ 2.25 did not show a significant
association with this outcome. For non-neurological mor-
bidity, birthweights below the third, fifth, or tenth centiles
on population chart and birthweights more than 2SD
below the population mean showed significant association
with this outcome, with summary odds ratios of a similar
magnitude. Subgroup analysis for individual morbidities
was only possible for birthweight below the tenth centile
on the population chart and neonatal hypoglycaemia (any
threshold, three studies, OR 3.72, 95% CI 0.85–
16.19),9,37,41 and seizures (two studies, OR 2.35, 95% CI
1.58–3.49).41,47
Quality assessment
The results for the quality assessment are presented in
Table 1. The majority of the studies included were of
cohort design (97%), and most were retrospective studies
(73%). Most studies were of high or moderate quality
according to our pre-specified criteria. Studies often failed
to adequately describe the test or outcome in a way that
would make them reproducible, and very few studies
Total studies identified from electronic searches
(database inception to January 2011) n = 36 956
Potentially relevant articles obtained in full manuscripts
n = 1606
Identified from electronic searches n = 1419
Identified from manual reference list checking n = 187
Articles excluded from review with reasons:
Not a measure of low birthweight n = 166
Inappropriate outcome measure n = 37
Lack of original data (review articles/letters) n = 384
Gestational age unreported n = 229
Duplicate publications n = 15
Incorrect population n = 106
Data not extractable n = 564
Papers unavailable n = 13
Total excluded n = 1514
Citations excluded n = 35 537
Selected for inclusion in overall review n = 92 (23 051 541 individuals)
Neonatal outcomes (this report) n = 29 (21 034 114 neonates)
Test No. of studies No. of neonates
Birthweight <2.5 kg 9 1 459 753
Birthweight other thresholds 8 1 138 755
Population growth chart <10th percentile 17 19 494 993
Population growth chart other percentiles 4 113 707
Customised growth chart <10th percentile 1 12 705
Ponderal index 3 22 028
Other measurements of fetal growth 4 80 118
Figure 1. Study selection process for systematic review of the prognostic and predictive ability of current birthweight standards for short- and
long-term outcomes.
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described any interventions that were performed between
the time of the birthweight measurement and the outcome
test. Where possible a subgroup analysis using only
high-quality studies was performed, and the results are pre-
sented in Table 2.
Subgroup analyses of prognostic association
The results for subgroup analyses to address potential con-
founding factors of the association between birthweight
and adverse neonatal outcome, within the meta-analysis
groups for each birthweight standard, are presented in
Table 2. No subgroup analyses were possible for neonatal
morbidity according to these criteria. Too few studies
reported ethnicity in enough detail to permit subgroup
analysis. Limiting to a singleton population slightly weak-
ened the association between birthweight below 1.5 kg and
neonatal death, but did not affect the association between
birthweight below 2.5 kg and the same outcome.
Birthweight as a continuous variable
None of the included studies that considered neonatal out-
comes examined birthweight as a continuous variable via
logistic regression analysis, so it is not possible to comment
on this further.
Direct comparison of prognostic association for
absolute versus population centiles
Only one study directly compared absolute birthweight and
centile on population chart in the same population. For
neonatal mortality, a birthweight below 2.9 kg had an odds
ratio of 2.64 (95% CI 1.45–4.82) and a birthweight below
the tenth centile on the population chart had an odds ratio
of 5.31 (95% CI 2.85–9.89) for the same outcome.38
Publication bias for prognostic association results
To examine funnel-plot asymmetry (small study effects),
and thus the potential for publication bias, the Peters test
was applied to the only meta-analysis containing ten or
more studies (birthweight below tenth centile and neonatal
mortality). There was no significant evidence of small study
effects in this group (P = 0.996).
Predictive ability of standards of low birth weight
to predict neonatal death
The outcome that had the strongest prognostic association
overall with low birth weight was neonatal death. For
birthweight tests with a large (OR > 5) and statistically sig-
nificant prognostic association with this outcome, their
predictive ability for individual babies was summarised by
0.2 0.5 1 2 5 10 100 1000
11.98 (7.85, 18.27)
5.86 (4.19, 8.22)
I2 = 55, Tau2 = 0.033
33.58 (3.03, 371.43)
7.40 (0.38, 144.11)
3.57 (2.21, 5.79)
4.11 (3.70, 4.56)
I2 = 18, Tau2 = 0.005, EPIb 3.37, 5.02
6.23 (3.08, 12.61)
8.01 (3.78, 17.0)
2.64 (1.45, 4.82)
8.46 (6.25, 11.46)
I2 = 77, Tau2 = 0.12, EPIb 3.34, 21.45
19.12 (4.54, 80.59)
I2 = 88, Tau2 = 1.35, EPIb too large
Birth weight < mean –2SD71
Birth weight < mean –1SD71,103
Fetal growth ratioa <0.8089
Fetal growth ratioa <0.7589
Ponderal Index (weight 
(g)/100x length(cm)3) ≤2.2582
Population chart <10th centile21,
56,65,67-69,74,82,100,110,115
Population chart ≤ 5th centile100
Population chart ≤ 3rd centile100
Birth weight <2.9kg69
Birth weight <2.5kg49,53,81,96,99,105,
106,118,
Birth weight <2.0kg53,96,120
Birth weight <1.5kg49,53,99,105 48.6 (28.62, 82.53)
I2 = 0, Tau2 = 0
odds ratio (95% confidence interval)
Definition
No. of
Studies 
No. of 
Individuals 
1,441,363
Year of birth
1961-2005
Odds ratio (95% CI)
539,124 1958-1998
1,458,983 1957-2005
9201 1981-1983
82,361 1988-1996
82,361 1988-1996
19,444,776 1981-2006
21,508 1981-1984
5,305 1980-1986
5,305 1980-1986
70,398 1989-1993
15,596 Unreported
4
3
8
1
1
2
1
1
1
1
13
1
a = observed weight/ 
population mean for 
gestational age
b = estimated prediction 
interval
Figure 2. Forest plot of odds ratios for the association between birthweight standards and neonatal mortality.
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using meta-analysis to calculate summary sensitivity, speci-
ficity, and likelihood ratios (Table 3). These measures
reveal the discriminative ability of each test and how test
results modify a baby’s odds of having a neonatal death.
For each test the specificities and positive likelihood ratios
were high, but the sensitivity and negative likelihood ratios
were generally poor (Table 3). This can be explained by the
fact that although a higher proportion of deaths occurred
within the low birthweight group, because this group
represents a small fraction of the overall population, a large
absolute number of deaths still occurred within the normal
weight groups, and therefore sensitivity is low and the ‘false
negative’ numbers are high, giving a poor negative likeli-
hood ratio (close to 1). For example, the highest positive
likelihood ratio was for birthweights below 1.5 kg, indicat-
ing that any baby under this weight multiplied their pre-t-
est odds of neonatal death by 49.1 (95% CI 27.3–88.5);
however, the negative likelihood ratio was only 1.01 (1.00–
1.01), indicating that the odds of death barely change after
a negative test result. Thus, although a birthweight below
1.5 kg substantially increases the odds of a poor outcome,
a birthweight above 1.5 kg does not increase the odds of a
good outcome.
Discussion
Main findings
Low birthweight showed a strong, consistent association with
neonatal mortality. The relationship was highest at lower
thresholds and gradually decreased (but remained strong) as
the threshold increased. The absolute birthweight seemed to
be more strongly related to this outcome than centiles on
population weight charts, especially for thresholds of 1.5 and
2.0 kg. Restricting the analysis to singletons, year of birth
since 1990, or by country of origin did not change the mag-
nitude of the association. Other definitions of fetal growth
restriction were based on single studies and showed mixed
results, but none appeared to be more strongly associated
with neonatal mortality than the absolute birthweight. The
results for neonatal morbidity were mixed, but no single def-
inition of growth restriction appeared to be consistently
more strongly associated with adverse outcomes than others.
All of the birthweight and population chart thresholds
assessed for predictive ability showed a high specificity and
positive likelihood ratio for neonatal death, and thus babies
who test positive are at a substantially higher risk of neonatal
mortality. However, each test generally had a low sensitivity
Birth weight < mean-2SD124 5.34 (2.96, 9.62)
Ponderal Index (100  x weight (g)
/length cm3) <10th centile23
3.57(1.34, 9.50)
Customised chart <10th centile47 2.49 (0.79, 7.82)
Population chart <10th centile8,23,47,68,80,
104
2.98 (1.58, 5.61)
I2 58, Tau2 0.32, EPIa 0.49,18.04
Population chart <5th centile8,104 5.08 (1.70, 15.2)
I2 64, Tau2 0.40
Population chart <3rd centile80 2.56 (1.65, 3.97)
Birth weight <2.5kg120 2.03 (0.71, 5.82)
Birth weight <2.0kg120 1.66 (0.76, 3.65)
Non-neurological morbidity
Ponderal Index
(weight(g)/100 x length cm3) ≤2.2566
14.54 (0.67, 316.7)
Customised chart <10th centile47 1.87 (0.99, 3.55)
Population chart <10th centile8,21,47,100 2.12 (1.56, 2.91)
I2 0, Tau2 0
Population chart ≤5th centile8,100 2.44 (1.50, 3.98)
I2 0, Tau2 0
Population chart ≤3rd centile80,100 3.54 (2.28, 5.52)
I2 0, Tau2 0
Birth weight <2.5kg120 4.28 (1.23, 14.92)
Birth weight <2.0kg120 17.34 (5.63, 53.70)
Neurological morbidity 
0.5 1 2 5 10 100 1000
odds ratio (95% confidence interval)
Definition
No. of
Studies 
No. of 
Individuals Year of birth Odds ratio (95% CI)
1 770 Unreported
1 770 Unreported
2 112,695 1988-2001
2 83,105 1988-1997
4 217,122 1988-2006
1 12,705 2001-2005
1 20 Unreported
1 770 Unreported
1 770 Unreported
1 30,334 2000-2001
2 1012 1988-1997
6 44,751 1984-2005
1 12,705 2001-2005
1 500 Unreported
1 4,415 1978
a = estimated prediction 
interval
Figure 3. Forest plot of odds ratios for the association of birthweight standards with neonatal morbidity.
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and negative likelihood ratio close to 1, and thus a negative
test result does not improve the odds that a baby will not
have a neonatal death.
Strengths and limitations
This review provides the best available evidence, at the time
of writing, regarding the association between different mea-
sures of fetal growth restriction and adverse outcomes. No
other review has attempted to compare different definitions
of growth restriction to inform clinical practice. The
strength of our review and the validity of our inferences lie
in the methodology used. We have complied with existing
guidelines for the reporting of systematic reviews of diag-
nostic and observational studies.13,55 We have used the
most up to date techniques for performing and interpreting
meta-analysis.56–58 An extensive literature search was per-
formed in relevant databases with no language restrictions
applied. Every effort was made to obtain the most complete
data set possible through contact with authors and experts
in the field. Peters test showed that there was no evidence
of small study bias within our largest meta-analysis; other
groups were too small to assess. We also considered both
the prognostic association of birthweight tests with out-
come (as summarised by an odds ratio) and their predic-
tive ability (as summarised by sensitivity, specificity, and
likelihood ratio).
There are several limitations to our review. Different
numbers of studies contributed to each analysis, and there
were few direct comparisons. Indeed, in the only study that
compared absolute birthweight and centile chart in the
same population, the association for birthweight below the
tenth centile was observed to be stronger than the associa-
tion with absolute birthweight below 2.9 kg, for this out-
come. There was a lack of data in some analyses, e.g.
customised centile charts and ponderal index in relation to
adverse outcome, but as every effort was made to acquire
both published and unpublished data we do not feel that
anything further could be done to address this. Although
Table 1. Methodological quality of studies included in systematic
review of birthweight standards for neonatal outcomes
Quality item Number (%) of studies n = 29
Yes No Unclear
Cohort study design 28 (97) 0 1 (3)
Population adequately
described
28 (97) 0 1 (3)
Consecutive recruitment 22 (76) 1 (3) 6 (21)
Prospective recruitment 6 (21) 21 (73) 2 (6)
Appropriate outcome
measure
29 (100) 0 0
Outcome measure blinded 0 0 29 (100)
>90% of individuals had
outcome measure
26 (90) 0 3 (10)
Index test and outcome
measure described
14 (48.5) 1 (3) 14 (48.5)
Intervention between index
test and outcome
1 (3) 0 28 (97)
Quality classification
High 24 (83) – –
Medium 4 (14) – –
Low 1 (3) – –
Table 2. Subgroup analysis according to birthweight standard and neonatal mortality, where possible, for study quality, year of birth of study
population, location of study, and singleton population
Birth weight standard Number of studies Subgroup OR (95% CI) Estimated
prediction
interval (EPI)
I2, s2
Neonatal death
Birthweight <1.5 kg 331,46,48 High-quality studies 53.29 (30.08–94.39) – I2 = 0, s2 = 0
Birthweight <1.5 kg 231,32 Singletons 41.85 (16.53–105.94) – I2 = 0, s2 = 0
Birthweight <2.5 kg 431,32,43,52 Singletons 8.39 (4.90–14.36) 0.86–81.36 I2 = 81, s2 = 0.20
Birthweight <2.5 kg 531,43,45,46,48 High-quality studies 8.15 (5.76–11.54) 2.40–27.66 I2 = 80, s2 = 0.12
Birthweight <2.5 kg 246,48 Year of birth ≥ 1990 9.74 (5.31–17.86) – I2 = 91, s2 = 0.17
Population chart
<10th centile
67,34,36,38,40,47 Singletons 4.03 (3.88–4.18) – I2 = 0, s2 = 0
Population chart
<10th centile
87,33,34,36,40,50,51 Year of birth ≥ 1990 4.23 (3.73–4.81) 3.23–5.55 I2 = 31, s2 = 0.01
Population chart
<10th centile
47,36,47,50 Congenital anomalies excluded 4.01 (3.86–4.16) – I2 = 0, s2 = 0
Population chart
<10th centile
67,34,36,47,50,51 Studies in USA/Europe 4.04 (3.89–4.19) – I2 = 0, s2 = 0
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every effort was made to control for potential confounding
factors through subgroup analysis, because of the quality
and reporting of the primary studies this was not always
possible. We strictly limited our review to infants born at
37 weeks of gestation or later to avoid the confounding
effect of preterm birth; however, the method of estimating
gestation in the primary studies was often inaccurate. Very
few studies used ultrasound measurement of crown–rump
length at 10–13 weeks of gestation, which is the most accu-
rate method59: the majority used the mother’s last men-
strual period and some used a clinical examination of the
newborn, which are less reliable and may have resulted in
preterm infants being included inadvertently. We also rec-
ognise that within the group of ‘term’ infants there is a
continuing spectrum of gestational age and birthweight,
and the risks are not equal, i.e. a baby at 37 weeks of gesta-
tion will have a higher risk of adverse outcome than a baby
at 40 weeks of gestation, irrespective of birthweight. How-
ever, as the majority of studies did not report outcomes
according to gestation and birthweight, we could not
examine this issue further with the current data. Current
clinical practice tends to group infants of 37 weeks of ges-
tation and over together in the way that they are managed,
so we feel that the approach in this review remains valid.
As a result of poor reporting in the primary studies, our
ability to perform subgroup analysis according to ethnicity
was limited. It is known that Afro-Caribbean and Asian
populations have smaller babies, and therefore it is likely
that the same thresholds would not give the same results in
all ethnic backgrounds.60 We did not analyse according to
social class: again this was not possible with the informa-
tion available. We limited the population to singletons
where possible, and found that this did not significantly
affect the results. We also recognised that the year of birth
may be an important factor in neonatal outcome, particu-
larly mortality, because of advances in neonatal care, and
therefore performed an analysis limited to studies where
the population was born in or after 1990. This did not sig-
nificantly alter the odds ratios for either birthweight below
the tenth centile on the population chart or birthweight
below 2.5 kg, the only groups for which this analysis was
possible. Customised charts may perform best in sub-
groups, such as women who are obese, and this type of
analysis was not possible.61
Comparing different standards of birthweight through
analyses using different populations may not give a true
result; however, no studies reported more than two stan-
dards in the same population, and only one study com-
pared absolute birthweight and population centile charts,
thereby limiting our ability to deal with this issue.
We attempted to consider all clinically important out-
comes within this review; however, one important adverse
outcome of fetal growth restriction that has been omitted
is stillbirth. This exclusion was made because the remit of
the project was to look at parameters of weight at birth
and subsequent adverse outcome, rather than tests per-
formed in the antenatal period. We also felt that there was
too much potential for confounding to examine the associ-
ation between birthweight and stillbirth, given that stillbirth
may occur days or weeks prior to delivery, and therefore
lead to the inclusion of premature infants in the analysis.
Interpretation
There is a vast literature exploring the relationship between
fetal growth restriction and adverse outcomes, using differ-
ent methodologies to do so. The aim of our review was to
consider the association and prediction of different thresh-
olds of birthweight or centile charts, and we therefore
excluded studies where 2 9 2 tables could not be obtained
from the original article or authors could not provide this.
We therefore could not make a complete assessment of the
association of birthweight as a continuous variable with
adverse health outcomes. In order to address this we con-
sidered whether the studies included in the review had
examined the association between a continuous birthweight
measure and adverse outcomes via logistic regression analy-
sis; however, no studies relating to neonatal outcomes had
performed this analysis. We did not identify any other
systematic reviews attempting to compare different stan-
dards of low birthweight with neonatal outcomes.
Table 3. Results for the predictive ability (sensitivity, specificity, and likelihood ratios) of different birthweight standards for neonatal mortality
Birthweight standard Sensitivity (95% CI) Specificity (95% CI) Positive likelihood
ratio (95% CI)
Negative likelihood
ratio (95% CI)
Birthweight <1.5 kg31,32,46,48 0.008 (0.004–0.146) 0.99 (0.99–1.00) 49.1 (27.3–88.5) 1.01 (1.00–1.01)
Birthweight <2.0 kg32,45,52 0.05 (0.03–0.07) 0.99 (0.99–1.00) 13.3 (2.27–78.28) 0.94 (0.85–1.02)
Birthweight <2.5 kg31,32,43,45,46,48,49,52 0.31 (0.19–0.47) 0.94 (0.88–0.97) 5.27 (3.57–7.76) 1.37 (1.15–1.62)
Population chart <3rd centile47 0.24 (0.12–0.41) 0.96 (0.96–0.96) 6.31 (3.57–11.14) 0.79 (0.66–0.94)
Fetal growth ratio <0.8044 0.67 (0.09–0.99) 0.94 (0.93–0.95) 11.9 (3.87–32.52) 0.36 (0.07–1.75)
Birthweight < mean – 2 SD39 0.13 (0.09–0.19) 0.99 (0.99–0.99) 10.53 (7.25–15.28) 0.88 (0.83–0.92)
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Our meta-analysis confirms that birthweight has a strong
prognostic association with neonatal mortality, with low
birthweight substantially increasing the risk of a poor out-
come. However, although specificity and positive likelihood
ratios were excellent, sensitivity was usually <0.5 and nega-
tive likelihood ratios were close to 1. This means that,
compared with the pre-test risk of neonatal death (preva-
lence), babies with a low birthweight (test positive) are at a
substantially increased risk, but the risk for those with a
normal birthweight (test negative) does not change.
Recommendations
Future research is necessary to establish whether there is a
birthweight standard that can accurately predict adverse
neonatal outcomes. Initially, it is important to compare the
different standards across the same population to enable an
unbiased comparison, and to further explore the standards
that were less frequently reported and therefore could not
be included in the meta-analysis within our review, such as
ponderal index and customised centile charts. This could
be performed through an individual patient data (IPD)
meta-analysis, where multiple definitions of fetal growth
restriction could be compared across the same population,
and factors such as ethnicity more adequately assessed.62
Important factors to consider in any future IPD analysis
are that of the accurate estimation of gestational age (i.e.
pregnancies dated by first-trimester ultrasound scan only)
and comparing outcome by week of gestational age rather
than grouping all term infants together. Another option
would be to perform further analysis on the large Scandi-
navian birth registries, which record a variety of birth
anthropometry that can be linked to health outcomes.63
Finally, it is likely that more accurate risk predictions
could be made using birthweight as a continuous variable,
rather than dichotomising it using a threshold, as is cur-
rently the general practice.64 The use of measures of func-
tional growth rather than weight alone, such as body
composition or metabolic parameters, may help to differ-
entiate between infants who are small because of growth
restriction, and therefore might be at higher risk of adverse
outcome, and those who are constitutionally small.65
Conclusion
Birthweight tests are strongly associated with neonatal mor-
tality and morbidity, especially at lower absolute birth-
weight thresholds, and babies that test positive (i.e.
abnormal growth) are at a substantially increased risk of
neonatal mortality; however, babies who test negative (i.e.
normal growth) do not have a decreased risk of neonatal
mortality. Further research is required to identify the
optimum definition of low birthweight that helps best pre-
dict the risk of adverse outcomes, and this may require
using birthweight as a continuous variable, developing
prognostic models that also contain other factors, and
using individual patient data meta-analysis.
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